Tenofovir-Diphosphate as a Marker of HIV Pre-exposure Prophylaxis Use Among East African Men and Women
Background: Controlled pharmacokinetic (PK) studies in United States populations have defined categories of tenofovir-diphosphate (TFV-DP) in dried blood spots (DBS) for various pre-exposure prophylaxis (PrEP) adherence targets. It is unknown how these categories perform in other populations. Theref...
Main Authors: | Maria Pyra, Pete Anderson, Jessica E. Haberer, Renee Heffron, Connie Celum, Stephen Asiimwe, Elly Katabira, Nelly R. Mugo, Elizabeth A. Bukusi, Jared M. Baeten |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00401/full |
Similar Items
-
Randomized controlled phase IIa clinical trial of safety, pharmacokinetics and pharmacodynamics of tenofovir and tenofovir plus levonorgestrel releasing intravaginal rings used by women in Kenya
by: Nelly R. Mugo, et al.
Published: (2023-06-01) -
Dynamic Perceived HIV Risk and Sexual Behaviors Among Young Women Enrolled in a PrEP Trial in Kenya: A Qualitative Study
by: Kenneth Ngure, et al.
Published: (2021-08-01) -
A Scoring Tool to Identify East African HIV-1 Serodiscordant Partnerships with a High Likelihood of Pregnancy.
by: Renee Heffron, et al.
Published: (2015-01-01) -
Tenofovir diphosphate in dried blood spots and HIV-1 resistance in South Africa
by: Y. Singh, et al.
Published: (2023-09-01) -
Knowledge and barriers of PrEP delivery among diverse groups of potential PrEP users in Central Uganda.
by: Timothy R Muwonge, et al.
Published: (2020-01-01)